Published in Am J Nephrol on January 15, 2010
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol (2012) 1.83
Effect of uremia on structure and function of immune system. J Ren Nutr (2012) 1.43
Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol (2013) 1.32
Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant (2011) 1.26
Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol (2012) 1.18
Immune dysfunction in uremia—an update. Toxins (Basel) (2012) 1.03
Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One (2011) 0.94
Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol (2010) 0.91
Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis. Biomed Res Int (2014) 0.82
Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int Suppl (2011) (2014) 0.81
Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis. Clin Exp Nephrol (2010) 0.79
Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol (2013) 0.77
Prophylactic vaccinations in chronic kidney disease: Current status. Hum Vaccin Immunother (2015) 0.75
Dendritic Cell Dysfunction in Patients with End-stage Renal Disease. Immune Netw (2017) 0.75
Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial. PLoS One (2017) 0.75
Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth (2010) 2.32
Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. Am Heart J (1999) 1.60
A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia (2008) 1.52
Effects of chronic spinal cord injury and pressure ulcer on 25(OH)-vitamin D levels. J Am Paraplegia Soc (1993) 1.46
Activation of intrinsic coagulation pathway in pre-eclampsia. Am J Med (1986) 1.41
Effects of cyclosporine on magnesium metabolism in rats. J Lab Clin Med (1989) 1.39
Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol (1981) 1.36
Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int (2006) 1.27
Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol (1993) 1.27
Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest (2000) 1.26
Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol (2007) 1.25
Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol (1985) 1.24
Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int (2006) 1.15
Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens (2000) 1.12
Renal magnesium wasting associated with amphotericin B therapy. Am J Med (1984) 1.12
Adhesion of viridans group streptococci to sialic acid-, galactose- and N-acetylgalactosamine-containing receptors. Oral Microbiol Immunol (2002) 1.11
Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab (2000) 1.10
Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension (1997) 1.10
Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol (1999) 1.08
Urolithiasis in patients with spinal cord injury. Paraplegia (1981) 1.07
Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol (1994) 1.06
Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens (1998) 1.06
Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens (2001) 1.04
Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension (1999) 1.03
Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int (2001) 1.03
Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res (1998) 1.02
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology (1997) 1.01
Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome. Am J Med Sci (1981) 1.01
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother (1997) 1.01
Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression. J Pharmacol Exp Ther (2000) 1.00
Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway. Genes Immun (2002) 0.99
Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency. Proc Natl Acad Sci U S A (1992) 0.98
Hemorrhagic pneumonitis after intravenous injection of charcoal lighter fluid. Ann Intern Med (1979) 0.97
Hemodialysis in treatment of acute chloral hydrate poisoning. South Med J (1977) 0.96
Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis. Ann Allergy (1994) 0.96
Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol (1999) 0.95
Nephrotoxicity of paraquat in man. Arch Intern Med (1979) 0.94
Compression neuropathy subsequent to renal transplantation. Urology (1976) 0.93
Renal senescence in 2008: progress and challenges. Int Urol Nephrol (2008) 0.92
Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs (1993) 0.92
Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol (1992) 0.91
Functional decline in aging and disease: a role for apoptosis. J Am Geriatr Soc (2001) 0.91
Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways. Am J Physiol (1999) 0.91
Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Kidney Int (1999) 0.91
Respiratory alkalosis. Respir Care (2001) 0.90
Bicarbonate-buffered peritoneal dialysis. An effective adjunct in the treatment of lactic acidosis. Am J Med (1979) 0.90
Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med (1981) 0.90
Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Diabetologia (2002) 0.89
Central retinal vein occlusion associated with hemodialysis. Am J Med Sci (1979) 0.89
Thyroid function studies in the nephrotic syndrome. Ann Intern Med (1979) 0.89
Vascular hyporesponsiveness in simulated microgravity: role of nitric oxide-dependent mechanisms. J Appl Physiol (1985) (2000) 0.89
Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. J Clin Invest (1991) 0.89
Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med (1984) 0.88
Cystic transformation of end-stage kidneys in patients undergoing hemodialysis. Int J Artif Organs (1980) 0.88
Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension (1998) 0.88
Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1996) 0.87
Femoral neuropathy: a complication of renal transplantation. Nephron (1981) 0.87
P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol (1993) 0.87
Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression. Kidney Int (2001) 0.87
Malignant or accelerated hypertension. West J Med (1984) 0.87
Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension (2000) 0.86
Nephrotic syndrome associated with adenocarcinoma of the breast. Am J Med (1980) 0.86
Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure. Am J Physiol Endocrinol Metab (2002) 0.86
Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate. AIDS Res Hum Retroviruses (1996) 0.86
Maintenance hemodialysis in myeloma kidney disease. West J Med (1977) 0.85
Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice. Antimicrob Agents Chemother (1997) 0.85
Evaluation of temafloxacin in a rat model of intra-abdominal abscess. J Antimicrob Chemother (1992) 0.85
Characteristics of the transport of oxalate and other ions across rabbit proximal colon. Pflugers Arch (1993) 0.85
TNF-alpha-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis. Genes Immun (2000) 0.85
Erythropoiesis associated with viral hepatitis in end stage renal disease. Am J Med Sci (1984) 0.85
Enhanced enteric excretion of urate in rats with chronic renal failure. Clin Sci (Lond) (1994) 0.85
Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension (1999) 0.84
Colorimetric rate method for the determination of creatinine as implemented by the Beckman Creatinine Analyzer 2. Am J Med Technol (1980) 0.84
HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure. Am J Physiol Renal Physiol (2004) 0.84
Conductive pathways for chloride and oxalate in rabbit ileal brush-border membrane vesicles. Am J Physiol (1998) 0.84
Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia (1983) 0.84
Salmonella typhimurium activates human immunodeficiency virus type 1 in chronically infected promonocytic cells by inducing tumor necrosis factor-alpha production. Biochem Biophys Res Commun (1994) 0.84
Role of NF-kappaB signaling pathway in increased tumor necrosis factor-alpha-induced apoptosis of lymphocytes in aged humans. Cell Death Differ (2005) 0.83
Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease. Am J Nephrol (2008) 0.83
Lung pathology in chronic hemodialysis patients. Int J Artif Organs (1982) 0.83
Nephrotic syndrome and coagulation and fibrinolytic abnormalities. Am J Nephrol (1983) 0.83
Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report. Int J Immunopharmacol (1994) 0.83
Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia (2007) 0.83
Acquired renal cystic disease in renal transplant recipients. Nephron (1984) 0.83
Down-regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int (1997) 0.83
Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am J Hypertens (1997) 0.83
Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma (1995) 0.82
Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int (1998) 0.82
The effect of modified transurethral sphincterotomy on autonomic dysreflexia. J Urol (1986) 0.82
Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. Arch Surg (1979) 0.82
Effects of experimental hemosiderosis on pancreatic tissue iron content and structure. Dig Dis Sci (1998) 0.82
Hepatobiliary pathology in hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol (1986) 0.82
Dialysis-induced changes in muscle strength. J Dial (1980) 0.82
Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun (2003) 0.82
Lead-induced hypertension. III. Increased hydroxyl radical production. Am J Hypertens (2001) 0.82